Dr Francis Beaudry is an Associate Professor at the veterinary biomedicine department of the Faculty of veterinary medicine of the Université de Montréal. He is an adjunct researcher at the Université de Montréal Hospital Research Centre (CRCHUM). Additionally, he has held leadership positions in bioanalysis within pharmaceutical companies prior his tenure at Université de Montréal. Combined, Dr Beaudry has 24 years of experience in mass spectrometry and bioanalysis. Dr Beaudry research is funded by the Natural Sciences and Engineering Research Council of Canada (NSERC).

LePr Francis Beaudry a obtenu un baccalauréat en chimie (Université de Sherbrooke) et un doctorat en chimie médicinale (Anglia Ruskin University). Il a poursuivi ses travaux de recherche sur le traitement pharmacologique de la douleur dans le laboratoire du Pr Pascal Vachon. Le Pr Beaudry est entré en fonction le 1er juin 2009 à titre de professeur adjoint au département de biomédecine vétérinaire de l'Université de Montréal, promu au rang de professeur agrégé le 1er juin 2014 et au rang de professeur titulaire le 1er juin 2020. Le Pr Beaudry a acquis une vaste expérience dans le domaine de la pharmacocinétique, du métabolisme des médicaments, de la spectrométrie de masse et de la bioanalyse. Le Pr Beaudry est l'auteur ou le coauteur de 141 publications dans des journaux scientifiques à comité de lecture et de 119 affiches présentées lors de congrès scientifiques nationaux et internationaux depuis le début de sa carrière scientifique.

• Membre de l'Ordre des chimistes du Québec

Publications (2017-2021)

J. Ben Salem, B. Nkambeu, D. Arvanitis and F. Beaudry (2021). Resiniferatoxin hampers the nocifensive response of Caenorhabditis elegans to noxious heat, and pathway analysis revealed that the Wnt signaling pathway is involved. Neurochemical Research. DOI 10.1007/s11064-021-03471-2

E. Eysseric, F. Beaudry, C. Gagnon and P. Segura (2021). Non-targeted screening of trace organic contaminants in surface waters by a multi-tool approach based on combinatorial analysis of tandem mass spectra and open access databases. Talanta, 230: 122293

B. Nkambeu, J. Ben Salem and F. Beaudry (2021). Eugenol and Other Vanilloids Hamper Caenorhabditis elegans Response to Noxious Heat. Neurochemical Research. 46(2):252-264

F. Rousseau-Blass, A.E. Cribb, F. Beaudry, D.S. Pang (2021). A Pharmacokinetic-Pharmacodynamic Study of Intravenous Midazolam and Flumazenil in Adult New Zealand White-Californian Rabbits (Oryctolagus cuniculus). Journal of the American Association for Laboratory Animal Science. https://doi.org/10.30802/AALAS-JAALAS-20-000084. 

J. Raulic, F. Beaudry, G. Beauchamp, M. Jalenques, N. Summa, S. Lair, W. A. Youcef  and C. Vergneau-Grosset (2021), Pharmacokinetic, pharmacodynamic, and toxicology study of robenacoxib in rainbow trout (oncorhynchus mykiss), Journal of Zoo and Wildlife Medicine, 52(2): DOI: 10.1638/2020-0130 

Y. Prud'homme, S. T. Ferrell, F. Beaudry, G. Beauchamp, S. Nichols, M. Desmarchelier (2021), Pharmacokinetics and clinical effects of a single oral dose of trazodone in the domestic goat (capra hircus) as a model for wild ruminants. Journal of Zoo and Wildlife Medicine, 51(4):896-904

C. Kwan, I. Frouni, S.G. Nuara, S. Belliveau, W. Kang, A. Hamadjida, D. Bédard, F. Beaudry, M. Panisset, J.C. Gourdon and P. Huot (2021). Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson’s disease. Neuropharmacology, 186:108465

M. Kermorgant, J. Ben Salem, J.S. Iacovoni, D. Calise, L. Dahan, B.P. Guiard, S. Lopez, O. Lairez, A. Lasbories, N. Nasr, A. Pavy Le-Traon, F. Beaudry, J.M. Senard, D.N. Arvanitis (2021). Cardiac sensory afferents modulate susceptibility to anxio-depressive behaviour in a mouse model of chronic heart failure. Acta Physiologica. 00:e13601 (J. Ben Salem is co-first author) 

C. Kwan, S. G. Nuara, D. Bédard, F. Gaudette, J. C. Gourdon, F. Beaudry, P. Huot (2021). Selective blockade of the 5-HT3 receptor alleviates dyskinesia and psychosis in the parkinsonian marmoset. Neuropharmacology. 182:108386

F. Beaudry and P. Huot (2020). The MPTP-lesioned marmoset model of Parkinson’s disease: determining the minimal efficacy threshold required to predict successful clinical trials. Journal of Neural Transmission. 127(10):1343-1358

I. Frouni, F. Gaudette, D. Bédard, C. Kwan, A. Hamadjida, F. Beaudry and P. Huot (2020), Development and validation of a sensitive HPLC-HESI-MS/MS method for quantitative determination of bitopertin in rat and marmoset plasma following sub-cutaneous administration. MNI Open Research 2020, 4:2

P.V. Steagall, H. L. Marcelle Ruel, T. Yasuda, B. Paglerani Monteiro, R. Watanabe, M. Cayetano Evangelista and F. Beaudry (2020). Pharmacokinetics and analgesic effects of intravenous, intramuscular or subcutaneous buprenorphine (Simbadol) in dogs undergoing ovariohysterectomy: a randomized, prospective, masked, clinical trial. BMC Veterinary Research. 16:154. 

B. Nkambeu, J. Ben Salem and F. Beaudry (2020). Capsaicin and its analogues impede nocifensive response of Caenorhabditis elegans to noxious heat. Neurochemical Research. 45(8): 1851-1859

J. Pelletier, J.-P. Rocheleau, C. Aenishaenslin, F. Beaudry, G. Dimitri, R. Lindsay, N. Ogden, C. Bouchard and P. Leighton (2020), Evaluation of fluralaner as an oral acaricide to reduce tick infestation in a wild rodent reservoir of Lyme disease. Parasites & Vectors. 13:73. 

L. Sid-Otmane, A. Hamadjida, S.G. Nuara, D. Bédard, F. Gaudette, J.C. Gourdon, V. Michaud, F. Beaudry, M. Panisset and P. Huot (2020). Selective metabotropic glutamate receptor 2 positive allosteric modulation alleviates L-DOPA-induced psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset. European Journal of Pharmacology. 873:172957

S. Leonelli, B. Nkambeu and F.Beaudry (2020). Impaired EAT-4 Vesicular Glutamate Transporter Leads to Defective Nocifensive Response of Caenorhabditis elegans to Noxious Heat. Neurochemical Research. 45(4):882-890. 

C. Kwan, D. Bédard, I. Frouni, F. Gaudette, F. Beaudry, A. Hamadjida and P. Huot (2020). Pharmacokinetic profile of the selective 5-HT₃ receptor antagonist ondansetron in the rat: an original study and a mini-review of the literature. Canadian Journal of Physiology and Pharmacology. 98(7):431-440

C.B. Larouche, R. Johnson, F. Beaudry, C. Mosley, Y.Gu, K.A. Zaman, H. Beaufrère and C. Dutton (2019), Pharmacokinetics of midazolam and its major metabolite 1-hydroxymidazolam in the ball python (Python regius) after intracardiac and intramuscular administrations, Journal of Veterinary Pharmacology and Therapeutics, 42(6):722-731. 

F. Gaudette, D. Bédard, C. Kwan, I. Frouni, A. Hamadjida, F. Beaudry and P. Huot (2019). Highly sensitive HPLC-MS/MS assay for the quantitation of ondansetron in rat plasma and rat brain tissue homogenate following administration of a very low subcutaneous dose. Journal of Pharmaceutical and Biomedical Analysis. 175:112766

P. Vogeleer, A.T. Vincent, S. M. Chekabab, S.J. Charette, A. Novikov, M. Caroff, F. Beaudry, M. Jacques, J. Harel (2019). Regulation of waaH by PhoB during Pi starvation promotes biofilm formation by Escherichia coli O157: H7. Journal of Bacteriology. 201(18). 

I. Frouni, A. Hamadjida, C. Kwan, D. Bédard, V. Nafade, F. Gaudette, S. G. Nuara, J. C. Gourdon, F. Beaudry and Philippe Huot, Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism. Neuropharmacology, 158:107725.

M. Saidi, S. Kamali and F. Beaudry (2019). Neuropeptidomics: Comparison of Parallel Reaction Monitoring and Data-Independent Acquisition for the Analysis of Neuropeptides using High-Resolution Mass Spectrometry. Biomedical Chromatography. e4523. 

M. Parent-Vachon, F. Beaudry, D. Carrier, G. Di Cristo and P. Vachon (2019). Exercise alleviates pain in female pregnant mice with neuropathic pain and its effects on reproductive performance. Biological Research for Nursing.  21(5):500-509.

C. Otis, M. Guillot, M. Moreau, J.-P. Pelletier, F. Beaudry and E. Troncy (2019). Sensitivity of functional neuropeptidomics in testing pregabalin analgesic efficacy in a rat model of osteoarthritis pain. Clinical and Experimental Pharmacology and Physiology. 46(8):723-733.

M. Kermorgant , J. Ben Salem, J. Santelli J., D. Calise D, A.C. Oster, O. Lairez O, C. Coudret, M. Verelst, C. Gales, J.M. Senard, F. Beaudry, A. Pavy-LeTraon, C. Roux, R. Mauricot and D. Arvanitis (2019). Evaluation of upconverting nanoparticles towards heart theranostics. PLoS One. 14(12):e0225729 (J. Ben Salem is co-first author)

I. Frouni, C. Kwan, D. Bedard, S. Belliveau, E. Bourgeois-Cayer, F. Gaudette, F. Beaudry, H. Adjia, P. Huot (2019). Effect of the selective 5-HT2A receptor antagonist EMD-281,014 on L-DOPA induced abnormal involuntary movements in the 6-OHDA-lesioned rat. Experimental Brain Research. 237 (1): 29-36

M. R. Desmarchelier, F. Beaudry, S.T. Ferrell and D. Frank (2019). Determination of the pharmacokinetics of a single oral dose of trazodone and its effect on the activity level of domestic pigeons (Columba livia). American Journal of Veterinary Research.  80(1): 102-109 

J.A. Gervais, C. Otis, B. Lussier, M. Guillot, J. Martel-Pelletier, J.P. Pelletier, F. Beaudry and E. Troncy (2019). Osteoarthritic pain model influences functional outcomes and spinal neuropeptidomics: A pilot study in female rats. Canadian Journal of Veterinary Research. 83 (2): 133-141 (C. Otis is co-first author)

J. Ben Salem, B. Nkambeu, D.N. Arvanitis and F. Beaudry (2018). Deciphering the Role of EGL-3 for Neuropeptides Processing in Caenorhabditis elegans using High-Resolution Quadrupole-Orbitrap Mass Spectrometry. Neurochemical Research. 43(11):2121-2131

B. Nkambeu, J. Ben Salem, S. Leonelli, F. Amin Marashi, and F. Beaudry (2019). EGL-3 and EGL-21 are required to trigger nocifensive response of Caenorhabditis elegans to noxious heat. Neuropeptides. 73: 41-48

A. Hamadjida, S. G Nuara, D. Bedard, F. Gaudette, F. Beaudry, J. C. Gourdon and P. Huot (2018). The extremely selective 5-HT2A antagonist EMD-281,014 reduces dyskinesia and psychosis in the parkinsonian marmoset. Neuropharmacology. 139:61-67

J.F. Sicard, P. Vogeleer, G. Le Bihan, Y. Rodriguez Olivera, F. Beaudry, M. Jacques and J. Harel, (2018) N-acetyl-glucosamine influences the biofilm formation of Escherichia coli, Gut Pathogens, 10:26.

F. Gaudette, A. Hamadjida, D. Bédard, S. G. Nuara, J. C. Gourdon, V. Michaud, F. Beaudry and P. Huot (2018). Development of a selective and sensitive high-performance liquid chromatography-tandem mass spectrometry assay to support pharmacokinetic studies of LY-487,379 in rat and marmoset. Journal of Chromatography B. 1093-1094:1-7

J. Benito, B. Monteiro, F. Beaudry and P. Steagall (2018), Efficacy and pharmacokinetics of bupivacaine with epinephrine or dexmedetomidine after intraperitoneal administration in cats undergoing ovariohysterectomy. Canadian Journal of Veterinary Research. 82(2): 124-130

J. Ben Salem, B. Nkambeu and F. Beaudry (2018), Characterization of Neuropeptide K Processing in Rat Spinal Cord S9 Fractions using High-Resolution Quadrupole-Orbitrap Mass Spectrometry, Biomedical Chromatography, 32(6):e4204.

C. Yang, G. Ghosh and F. Beaudry (2018), Detection of Gelatin Adulteration using Bio-informatics, Proteomics and High-Resolution Mass Spectrometry. Food Additives and Contaminants. 35(4): 599–608

S.F. Salmin, MC Giroux, P. Vachon and F. Beaudry (2017), In Vitro Metabolism of Specific CYP2D and CYP3A Opioid Substrates using Rat Liver S9 Fractions and Mass Spectrometry Reveal a Severe Metabolic Impairment with Increasing Age. Biomedical Chromatography, 31(2):e3786

E. Eysseric, K. Barry, F. Beaudry, M. Houde, C. Gagnon and P.A. Segura (2017), Application of spectral accuracy to improve the identification of organic compounds in environmental analysis. Analytical Chemistry, 89(18):9805-9813

F. Gaudette, A. Hamadjida, D. Bédard, S. Nuara, F. Beaudry and P. Huot (2017), Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method to quantify LY 354,740 in rat and marmoset plasma, Journal of Chromatography B, 1061-1062:392-398. 

M. Rhouma, J.M. Fairbrother, F.Beaudry, and A. Letellier (2017), Post weaning diarrhea in pigs: risk factors and non-colistin-based control strategies, Acta Veterinaria Scandinavica, 59(1):31.

G. Doodnaught, B. Monteiro Steagal, J. Benito, D. Edge, F. Beaudry, L. Pelligand and P. Steagll (2017), Pharmacokinetic and pharmacodynamic modelling after subcutaneous, intravenous and buccal administration of a high-concentration formulation of buprenorphine in conscious cats. PlosOne, 12(4):e0176443. 

G. Le Bihan, P. Garneau, A. Bernalier-Donadille, A. Gobert, A. Garrivier, C. Martin, A. Hay, F. Beaudry, G. Jubelin and J. Harel (2017). N-Acetylglucosamine sensing by NagC contributes to gut colonization by regulating LEE genes in EHEC. Frontiers Microbiology, 7:134.

M. Rhouma, J.M. Fairbrother, W. Thériault, F.Beaudry, N. Bergeron, S. Laurent Lewandowski and A. Letellier (2017), The fecal presence of enterotoxin and F4 genes as an indicator of efficacy of treatment with colistin sulfate in pigs, BMC Microbiology, 17:6

A. Riuz, E. Husby, C, Yang, G. Ghosh and F. Beaudry (2017), Detection of meat species adulteration using high-resolution mass spectrometry and a proteogenomics strategy. Food Additives and Contaminants.  34(7):1110-1120.

M. Saidi and F. Beaudry (2017), Targeted High-Resolution Quadrupole-Orbitrap Mass Spectrometry Analyses Reveal a Significant Reduction of Tachykinin and Opioid Neuropeptides Level in PC1 and PC2 Mutant Mouse Spinal Cords, Neuropeptides, 65:37-44

C. Otis, M. Guillot, M. Moreau, J. Martel-Pelletier, JP Pelletier, F. Beaudry, E. Troncy (2017), Spinal Neuropeptide Modulation and Cartilage Lesions in a Monosodium Iodoacetate Rat Model of Osteoarthritis. Neuropeptides, 65:56-62